Cargando…
Real-World Eligibility for Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Patients in Korea: Data from the Korean Acute Heart Failure (KorAHF) Registry
BACKGROUND AND OBJECTIVES: Sacubitril/valsartan (SV, LCZ696), the first in class drug, called as angiotensin receptor-neprilysin inhibitor (ARNI) can reduce heart failure (HF) hospitalization and cardiovascular mortality. However, SV prescription rate remains still low despite current HF guideline r...
Autores principales: | Oh, Jaewon, Lee, Chan Joo, Park, Jin Joo, Lee, Sang Eun, Kim, Min-Seok, Cho, Hyun-Jai, Choi, Jin-Oh, Lee, Hae-Young, Hwang, Kyung-Kuk, Kim, Kye Hun, Yoo, Byung-Su, Choi, Dong-Ju, Baek, Sang Hong, Jeon, Eun-Seok, Kim, Jae-Joong, Cho, Myeong-Chan, Chae, Shung Chull, Oh, Byung-Hee, Kang, Seok-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Heart Failure
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536672/ https://www.ncbi.nlm.nih.gov/pubmed/36262737 http://dx.doi.org/10.36628/ijhf.2019.0007 |
Ejemplares similares
-
Management and Prognosis of Heart Failure in Octogenarians: Final Report from the KorAHF Registry
por: Oh, Gyu Chul, et al.
Publicado: (2020) -
Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF)
por: Lee, Sang Eun, et al.
Publicado: (2017) -
Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction: Results from The Korea Acute Heart Failure (KorAHF) Registry
por: Kim, Sung-Hwan, et al.
Publicado: (2018) -
Impact of Cardiac Troponin Elevation on Mortality of Patients with Acute Heart Failure: Insights from the Korea Acute Heart Failure (KorAHF) Registry
por: Lee, Nuri, et al.
Publicado: (2022) -
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
por: Choi, Ki Hong, et al.
Publicado: (2018)